Table 1.
Descriptive statistics, odds ratios, and 95% confidence intervals bivariate and multivariate models of the risks of fecal viral RNA‐positive detection
| Patient Characteristics | Fecal viral RNA positiveN = 24 (%) | Fecal viral RNA negativeN = 90 (%) | ORb [95% IC](P‐value) | aORc [95% CI](P‐value) |
|---|---|---|---|---|
| Clinical characteristics | ||||
| Male sex, no (%) | 14 (58.3) | 39 (43.3) | 2.5 [0.8‐8.7] (0.1) | 2.5 [1.0‐6.7] (0.05) |
| Mean age, y (SD)a | 37.4 ± 21.4 | 33.3 ± 22.2 | ||
| 0‐4 y | 2 (8.3) | 5 (5.6) | 0.33 [0.01‐7.3] (0.6) | |
| 5‐14 y | 6 (25) | 20 (22.2) | 0.45 [0.04‐5.5] (0.6) | |
| 15‐44 y | 4 (16.6) | 37 (41.1) | 0.17 [0.02‐1.8] (0.2) | |
| 45‐64 y | 9 (37.5) | 21 (23.3) | 1.8 [0.3‐17.2] (0.6) | 4.8 [1.7‐14.5] (0.01) |
| >65 y | 3 (12.5) | 7 (7.7) | 0.6 [0.04‐8.4] (0.7) | |
| Digestive disorders <7 days | 4 (16.67) | 9 (10) | 2.6 [0.48‐12.7] (0.3) | |
| Vaccination against seasonal influenza | 2 (8.3) | 7 (7.8) | 0.4 [0.04‐46] (0.6) | |
| Influenza risk factors | 7 (29) | 27 (30) | 0.6 [0.1‐2.7] (0.6) | |
| Hospitalization | 3 (12.5) | 6 (6.7) | 7.0 [1.1‐45] (0.07) | 7.8 [1.7‐33.7] (0.02) |
| High fever (>39°C) | 17 (70.8) | 54 (60) | 2.8 [0.8‐11.7] (0.19) | 2.6 [1.7‐33.7] (0.1) |
| Dyspnea | 7 (29.2) | 18 (20) | 2.2 [0.6‐8.8] (0.33) | 4.4 [1.1‐20] (0.05) |
| Gastrointestinal symptoms | 13 (54.17) | 53 (58.89) | 0.8 [0.2‐2.7] (0.7) | |
| Diarrhea | 4 (16.67) | 11 (12.22) | 1.9 [0.3‐9.5] (0.5) | |
| Vomiting | 2 (8.33) | 8 (8.89) | 0.9 [0.1‐10.2] (0.9) | |
| Nausea | 6 (25) | 27 (30) | 0.8 [0.2‐2.7] (0.7) | |
| Abdominal pain | 8 (33.33) | 38 (42.22) | 0.6 [0.1‐3.2] (0.6) | |
| Food consumption | ||||
| Raw shellfish and mollusks | 4 (16.67) | 3 (3.33) | 19.6 [2.2‐254] (0.03) | 16.7 [3.6‐90.9] (0.00) |
| Cooked shellfish and mollusks | 1 (4.17) | 2 (2.22) | 1.7 [0.1‐42.7] (0.7) | |
| Tap water | 13 (54.17) | 55 (61.11) | 0.6 [0.1‐1.9] (0.5) | |
| Drug consumption before consultation | ||||
| Antibiotics | 1 (4.17) | 3 (3.33) | 2.3 [0.1‐28] (0.5) | |
| Antiviral | 1 (4.17) | 2 (2.22) | 11.7 [2.6‐56.8] (0.007) | |
| Drug consumption after consultation | ||||
| Antibiotics | 7 (29.17) | 8 (8.89) | 5.2 [1.4‐22] (0.04) | 6.4 [2.1‐19.8] (0.006) |
| Antiviral | 4 (16.67) | 6 (6.67) | 2.7 [0.5‐12.9] (0.07) | 7.4 [1.9‐29] (0.01) |
a
P = .3
b
Crude odds ratios (ORs) from bivariate models.
c
aOR = adjusted odds ratios from multivariate models.
CI: confidence interval.